IL165239A0 - Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant - Google Patents

Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant

Info

Publication number
IL165239A0
IL165239A0 IL16523903A IL16523903A IL165239A0 IL 165239 A0 IL165239 A0 IL 165239A0 IL 16523903 A IL16523903 A IL 16523903A IL 16523903 A IL16523903 A IL 16523903A IL 165239 A0 IL165239 A0 IL 165239A0
Authority
IL
Israel
Prior art keywords
preparation
synthetic lipid
lipid mixtures
improved synthetic
reconstituted surfactant
Prior art date
Application number
IL16523903A
Other languages
English (en)
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of IL165239A0 publication Critical patent/IL165239A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Steroid Compounds (AREA)
IL16523903A 2002-05-17 2003-05-12 Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant IL165239A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI001058A ITMI20021058A1 (it) 2002-05-17 2002-05-17 Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
PCT/EP2003/004937 WO2003097695A1 (en) 2002-05-17 2003-05-12 Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant

Publications (1)

Publication Number Publication Date
IL165239A0 true IL165239A0 (en) 2005-12-18

Family

ID=11449919

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16523903A IL165239A0 (en) 2002-05-17 2003-05-12 Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant
IL165239A IL165239A (en) 2002-05-17 2004-11-16 Reconstituted surfactant comprising an artificial sp-c peptide analog and a phospholipid mixture, a process for its production and use thereof in the manufacture of medicaments for treating pulmonary dysfunction

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL165239A IL165239A (en) 2002-05-17 2004-11-16 Reconstituted surfactant comprising an artificial sp-c peptide analog and a phospholipid mixture, a process for its production and use thereof in the manufacture of medicaments for treating pulmonary dysfunction

Country Status (26)

Country Link
US (2) US7511011B2 (enExample)
EP (1) EP1506234B1 (enExample)
JP (1) JP4883906B2 (enExample)
KR (1) KR101028927B1 (enExample)
CN (1) CN100347193C (enExample)
AT (1) ATE353919T1 (enExample)
AU (1) AU2003233320B2 (enExample)
CA (1) CA2486152C (enExample)
CY (1) CY1106667T1 (enExample)
DE (1) DE60311798T2 (enExample)
DK (1) DK1506234T3 (enExample)
EA (1) EA007928B1 (enExample)
ES (1) ES2282627T3 (enExample)
HR (1) HRP20041058B1 (enExample)
IL (2) IL165239A0 (enExample)
IT (1) ITMI20021058A1 (enExample)
MA (1) MA27960A1 (enExample)
MX (1) MXPA04011369A (enExample)
NZ (1) NZ536606A (enExample)
PL (1) PL209649B1 (enExample)
PT (1) PT1506234E (enExample)
SI (1) SI1506234T1 (enExample)
TN (1) TNSN04219A1 (enExample)
UA (1) UA79609C2 (enExample)
WO (1) WO2003097695A1 (enExample)
ZA (1) ZA200409215B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
ZA200507806B (en) 2003-03-24 2007-03-28 Actimis Pharmaceuticals Inc 2-phenoxy- and 2-enysulfomamide derivatives with CCR3 antagonistic acitivity for the treatment of asthma and other inflammatory or immunolgical disorders
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
UA76074C2 (en) * 2005-11-09 2006-06-15 O V Palladin Inst Of Biochemis Calmophil, pharmaceutical composition for substitution therapy aimed at recovering malfunctioned surfactant system of lungs
CN103169947B (zh) 2006-10-13 2014-10-29 奇斯药制品公司 具有改进性质的重组表面活性剂
CA2718130A1 (en) 2007-03-29 2008-10-09 National Jewish Health Surfactant lipids, compositions thereof, and uses thereof
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
EP2022798A1 (en) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
CN101980721B (zh) 2008-04-02 2013-03-13 国立大学法人德岛大学 含有合成肽的抗原药物赋形剂和使用其的粘膜疫苗
US8399406B2 (en) * 2009-06-05 2013-03-19 Chiesi Farmaceutici S.P.A. Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
WO2012028526A2 (en) * 2010-08-30 2012-03-08 F. Hoffmann-La Roche Ag Tetranectin-apolipoprotein a-i, lipid particles containing it and its use
CA2838070A1 (en) 2011-08-25 2013-02-28 F. Hoffmann-La Roche Ag Shortened tetranectin-apolipoprotein a-i fusion protein, a lipid particle containing it, and uses thereof
EP2922868B1 (en) 2012-11-21 2017-09-27 Chiesi Farmaceutici S.p.A. Reconstituted pulmonary surfactants

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2163860A1 (en) * 1993-06-30 1995-01-12 Chung C. Hsu Method for preparing liposomes
WO1997035882A1 (en) * 1996-03-27 1997-10-02 Ortho Pharmaceutical Corporation Lyophilized pulmonary surfactant peptide compositions
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
AU2001245848A1 (en) * 2000-03-15 2001-10-23 Advanced Research And Technology Institute Oral tolerance induction by collagen to prevent allograft rejection
EP1276495B1 (en) 2000-04-12 2006-04-19 ALTANA Pharma AG Use of recombinant pulmonary surfactant for the early treatment of acute pulmonary diseases
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1997502A1 (en) 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
EP2022798A1 (en) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides

Also Published As

Publication number Publication date
HK1079221A1 (zh) 2006-03-31
DE60311798D1 (de) 2007-03-29
ES2282627T3 (es) 2007-10-16
JP2006504635A (ja) 2006-02-09
US7511011B2 (en) 2009-03-31
DE60311798T2 (de) 2007-10-31
MA27960A1 (fr) 2006-07-03
AU2003233320B2 (en) 2008-06-19
TNSN04219A1 (en) 2007-03-12
US20080242589A1 (en) 2008-10-02
DK1506234T3 (da) 2007-06-11
CA2486152C (en) 2012-09-11
EP1506234B1 (en) 2007-02-14
AU2003233320A2 (en) 2003-12-02
EA007928B1 (ru) 2007-02-27
JP4883906B2 (ja) 2012-02-22
KR101028927B1 (ko) 2011-04-12
AU2003233320A1 (en) 2003-12-02
EA200401385A1 (ru) 2005-08-25
US20050176625A1 (en) 2005-08-11
IL165239A (en) 2012-10-31
CN100347193C (zh) 2007-11-07
ITMI20021058A0 (it) 2002-05-17
WO2003097695A1 (en) 2003-11-27
PL372751A1 (en) 2005-08-08
ATE353919T1 (de) 2007-03-15
CY1106667T1 (el) 2012-05-23
CA2486152A1 (en) 2003-11-27
SI1506234T1 (sl) 2007-06-30
CN1653088A (zh) 2005-08-10
HRP20041058B1 (hr) 2013-11-22
KR20050016408A (ko) 2005-02-21
US7842664B2 (en) 2010-11-30
PL209649B1 (pl) 2011-09-30
EP1506234A1 (en) 2005-02-16
ITMI20021058A1 (it) 2003-11-17
PT1506234E (pt) 2007-05-31
ZA200409215B (en) 2006-02-22
NZ536606A (en) 2006-10-27
HRP20041058A2 (en) 2005-02-28
UA79609C2 (en) 2007-07-10
MXPA04011369A (es) 2005-02-17

Similar Documents

Publication Publication Date Title
CY1106667T1 (el) Βελτιωμενα συνθετικα μιγματα λιπιδιων για την παρασκευη μιας ανασυγκροτημενης επιφανειοδραστικης ουσιας
BG105764A (en) Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
PT2078038E (pt) Agentes tensioativos reconstituídos apresentando propriedades melhoradas
MY159464A (en) Reconstituted surfactant composition containing analogs of surfactant protein b (sp-b) and surfactant protein c (sp-c)
AR025899A1 (es) Metodo para el uso de proteina de soja aislada en la produccion de analogos de queso fresco, no madurados, y analogos de queso y queso duro madurado
MX2009012675A (es) Tensioactivos reconstituidos que tienen propiedades mejoradas.
WO2006071796A3 (en) Pulmonary surfactant formulations
MXPA05013929A (es) Membranas virales reconstruidas funcionalmente que contienen un adyuvante.
WO2013120058A3 (en) Novel sp-b & sp-c peptides, synthetic lung surfactants, and use thereof
ATE503768T1 (de) Synthetische lungensurfactant peptide
DE69332654D1 (de) Fragmente eines oberflächenaktiven lungenproteins
JP2006504635A5 (enExample)
AR038642A1 (es) Tensioactivos pulmonares que contienen una polimixina para mejorar las propiedades superficiales
EA200501684A1 (ru) Новые липидные смеси для синтетических сурфактантов
GB0114240D0 (en) Concealed air breathing of shoe sole
UA26313A (uk) Засіб для замісhої терапії захворюваhь дихальhих шляхів, переважhо при сиhдромі задухи
CN309264527S (zh) 鼻基底假体(peek聚醚醚酮)
ES2092969A1 (es) Surfactante pulmonar natural de origen porcino.
AU2003266968A1 (en) In-situ production of suspension concentrate of diphenyl ether and n-(phosphono-methyl)glycine or homoalaninylmethyl-phosphinate herbicidal compositions and methods of use